1953–1998

The tobacco industry's manufactured-doubt campaign

In December 1953, with laboratory and epidemiological studies linking cigarettes to lung cancer reaching the general press, the heads of the major American tobacco companies met at the Plaza Hotel in New York and retained the public relations firm Hill and Knowlton. The approach the firm proposed, as the historian Allan Brandt reconstructs it from the firm's files, was not to deny the science but to take hold of it: to call for more research, fund it conspicuously, publicise every sceptic, and so keep the question looking open. The result was a jointly funded research committee, a newspaper advertisement called A Frank Statement to Cigarette Smokers, and a position held in public for more than four decades, that a causal link between smoking and disease had not been proven. It is treated here as an influence operation because it had what such operations have: coordinated actors, concealed purposes, intermediaries presented as independent, and a defined effect sought in a mass audience. It differs from the other cases in this collection in one respect. The evidence comes not from outside inference but from millions of pages of the participants' own records and from the findings of a court.

Attribution

The major US cigarette manufacturers and two jointly funded trade bodies, the Tobacco Industry Research Committee (from 1964 the Council for Tobacco Research) and the Tobacco Institute, acting together as what a US federal court found to be a racketeering enterprise.

Attributed by: The US District Court for the District of Columbia, in United States v. Philip Morris USA, Inc., 449 F. Supp. 2d 1 (D.D.C. 2006), upheld in large part on appeal. The US Surgeon General reached a consistent conclusion in 2014. The findings rest heavily on the companies' own internal documents.

Confidence, in their words: Judicial findings of fact and conclusions of law, made after a nine-month trial under the civil standard of proof and upheld on appeal. The district court found that the defendants violated the Racketeer Influenced and Corrupt Organizations Act, finding that they had for decades fraudulently misled the American public about the health effects of smoking and environmental tobacco smoke, the addictiveness of nicotine, the health benefits of low tar and light cigarettes, and the manipulation of cigarette design to sustain addiction. The trial judge wrote that the defendants had marketed and sold their lethal product with zeal, with deception, with a single-minded focus on their financial success, and without regard for the human tragedy or social costs that success exacted. The Supreme Court declined to review the case in 2010.

Objective

To protect cigarette sales and to avoid regulation and legal liability by preventing the public, the press, physicians and legislators from treating the harm of smoking as settled. A 1969 Brown and Williamson planning document put the aim in a sentence that has become the standard summary: doubt is our product, since it is the best means of competing with the body of fact that exists in the mind of the general public, and it is also the means of establishing a controversy. The federal court found that the purpose extended over time to nicotine addiction, secondhand smoke and the supposed benefits of low-tar cigarettes.

Target audiences

  • Smokers and people considering starting, who were offered a reason to postpone a decision
  • Journalists and editors, encouraged to present the question as a two-sided scientific debate
  • Physicians and scientists, including potential grant recipients
  • Legislators, regulators and their staff
  • Judges and juries in product liability cases

Timeline

  1. December 1953
    Tobacco company chief executives meet at the Plaza Hotel in New York in response to published research linking smoking to lung cancer, and engage Hill and Knowlton. The strategy adopted is to contest the science through sponsorship of research and promotion of sceptical scientists rather than through flat denial.
  2. 4 January 1954
    A Frank Statement to Cigarette Smokers runs as a full-page advertisement in more than 400 newspapers. It says the companies accept an interest in people's health as a basic responsibility, states their belief that their products are not injurious to health, and announces the Tobacco Industry Research Committee. A prominent geneticist sceptical of the epidemiology is appointed scientific director.
  3. 1958
    The companies create the Tobacco Institute to handle lobbying and public relations, leaving the research committee to maintain a scientific profile.
  4. January 1964
    The first Surgeon General's report concludes that cigarette smoking causes lung cancer. The industry's public position does not change. The research committee is renamed the Council for Tobacco Research a few weeks later.
  5. 1969
    A Brown and Williamson document titled Smoking and Health Proposal sets out the rationale for an advertising campaign to counter what it calls the anti-cigarette forces and contains the doubt is our product passage.
  6. 1970s – 1980s
    The same approach is extended to new evidence. Oreskes and Conway document the recruitment of eminent scientists from unrelated fields to direct research programmes and to challenge findings on secondhand smoke, and trace how the people and methods later reappeared in disputes over acid rain, the ozone layer and climate change.
  7. 1994
    Executives of the major companies testify before a committee of the US Congress that they do not believe nicotine is addictive. In the same period, internal Brown and Williamson documents reach academics and the press, beginning the large-scale disclosure of company records.
  8. November 1998
    The Master Settlement Agreement between the largest manufacturers and the attorneys general of 46 states resolves state claims for health costs, restricts marketing, and requires the research council and the Tobacco Institute to be disbanded. Internal documents produced in litigation become the basis of the public archive now held at the University of California, San Francisco.
  9. 1999 – 2006
    The US Department of Justice sues the manufacturers and the two trade bodies under civil racketeering law in September 1999. On 17 August 2006, after a nine-month trial, the court issues a 1,683-page opinion finding liability.
  10. 2009 – 2010
    The appeals court upholds the findings in large part and the Supreme Court declines review in June 2010. Implementation of the order then proceeds, including court-approved corrective statements on the health effects of smoking, addiction, low-tar cigarettes and secondhand smoke.

Channels

  • Paid newspaper advertising, beginning with the Frank Statement
  • Press releases, briefings and background material supplied to journalists by the Tobacco Institute and by Hill and Knowlton
  • Research grants to universities and medical schools, announced publicly
  • Scientific journals, conferences and sponsored symposia
  • Testimony to legislatures and regulators
  • Expert witnesses in litigation

Techniques

Manufactured Doubt

The central method, named in the industry's own words in the 1969 Brown and Williamson document. The companies did not need the public to believe smoking was safe. They needed people to believe the matter was unresolved, which was enough to justify not quitting, not regulating and not finding liability.

Manufactured Controversy

Brandt shows Hill and Knowlton working from 1954 to convert a growing scientific consensus into an apparent controversy, by circulating the views of a small number of sceptics and insisting that statistical evidence could not prove causation. The 1969 document states the purpose plainly: establishing a controversy at the public level.

Front Groups

The Tobacco Industry Research Committee was presented as a disinterested scientific body with an independent advisory board. The federal court found that it and its successor served the companies' public relations and legal needs. Brandt notes that the Tobacco Institute was created in 1958 so that overt lobbying would not compromise the research committee's scientific appearance.

Red Herring

Brandt documents that the research committee directed its grants largely toward basic work in genetics, immunology and virology, subjects unlikely to implicate cigarettes, while describing the programme publicly as a search for the truth about smoking and health.

Expert Shopping

Scientists were selected for their existing scepticism and their standing. The first scientific director was a well-known geneticist who held that cancer was chiefly hereditary. Oreskes and Conway describe the later recruitment of distinguished physicists with no background in medicine to lead research programmes and lend their authority.

Authority

Grants to respected universities and medical schools were publicised as evidence of good faith, and the reputations of the recipients were attached to the industry's position whether or not their research bore on smoking. Brandt argues that this practice created the modern problem of conflicts of interest in biomedical science.

Moving the Goalposts

Each body of evidence was met with a demand for a different kind. Epidemiology was dismissed as mere statistics, animal experiments as not applicable to humans, and both together as falling short of proof of mechanism. The call for more research, made continuously from 1954, had no stated end point.

False Balance

The public relations effort relied on the journalistic convention of giving both sides. By ensuring that an industry-supplied scientist or statement was always available for comment, the campaign obtained equal billing for a position that had little support among researchers, a dynamic analysed at length by Oreskes and Conway.

Information Withholding

The federal court found that the companies' internal research and the views of their own scientists were consistent with the public health consensus on disease and addiction while their public statements said the opposite, and that the defendants suppressed and concealed research and documents.

Health-Washing

The court found that the companies marketed filtered, low-tar and light cigarettes in ways that suggested reduced harm, while knowing that smokers compensate by inhaling more deeply and that such cigarettes offered no clear health benefit. The remedy included a ban on descriptors such as light and low tar.

Actors, behaviors, content

Actors. Competing corporations acting jointly through shared institutions: a research funding body, a lobbying and public relations institute, outside public relations counsel and law firms. The court found that company lawyers played a central role in directing research funding and in controlling what was disclosed. Most of the scientists who received grants were not party to the strategy.

Behaviors. Coordinated public statements by nominal competitors, concealment of internal knowledge, sponsorship of research selected for its public relations or litigation value, cultivation of journalists, and the routing of industry positions through bodies and individuals presented as independent. The conduct was sustained for decades and adapted to each new area of evidence.

Content. A small number of stable claims: causation has not been proven; the evidence is merely statistical; many factors cause cancer; more research is needed; responsible scientists disagree; and, later, nicotine is not addictive and secondhand smoke has not been shown to be harmful. The Frank Statement paired these with a promise of responsibility and cooperation with public health authorities.

Did it work? What is actually known

There is better evidence of effect here than for any other operation in this collection, though it still falls short of a precise estimate. Robert Proctor reports that the industry measured the impact of its own messaging and found it successful, and that as late as 1960 only about one-third of US doctors believed the case against cigarettes had been established. The practical outcomes the campaign sought were largely obtained for decades: Brandt records that for decades the companies did not lose a smoker's liability case, and their public position on causation was maintained for more than forty years after the first Surgeon General's report. The US Surgeon General concluded in 2014 that the tobacco epidemic was initiated and has been sustained by the aggressive strategies of the tobacco industry, which deliberately misled the public on the risks of smoking cigarettes, and estimated more than 20 million premature deaths in the United States from smoking between 1964 and 2014. What cannot be stated is how many of those deaths are attributable to the doubt campaign specifically, as distinct from nicotine addiction, advertising, low prices and social custom. Adult smoking prevalence in the United States did fall throughout the period, from 42.4 per cent in 1965 to 18.1 per cent in 2012, so the campaign slowed a decline rather than prevented one. Historians generally hold that the delay was substantial and costly. No one has produced an agreed number, and claims that do so should be treated with caution.

How it was caught

Not by outside detection. For forty years critics could see what the industry was doing but could not prove what it knew. That changed in the 1990s through a whistleblower's delivery of internal Brown and Williamson documents, state lawsuits whose discovery process forced the production of millions of pages, and the 1998 settlement, which required that the documents be made public. They are now searchable in the Truth Tobacco Industry Documents archive at the University of California, San Francisco. Historians including Brandt and Proctor reconstructed the strategy from those files, and the Department of Justice used them at trial. The 2006 judgment required the companies to keep their document websites open for a further fifteen years. The decisive evidence was the gap between what the companies wrote privately and what they said publicly.

Lessons

  • »Doubt is cheaper than persuasion. The campaign never had to convince anyone that smoking was healthy. It only had to make the question seem open. When someone benefits from your not deciding, the claim that the science is unsettled is doing work for them, and it is reasonable to ask what evidence would settle it and whether that evidence already exists.
  • »Ask who funds the institute. Bodies with neutral, scientific-sounding names were created and paid for by the companies whose product was in question. Funding does not make research wrong, but an organisation that does not disclose it plainly has made a choice about what readers should know.
  • »Distinguish the state of the evidence from the existence of a dissenter. A credentialed sceptic can be found on almost any question. What matters is the weight of evidence across the field and whether the dissenter works in it. Expertise in physics is not expertise in epidemiology.
  • »A call for more research can be a delaying tactic. More research is nearly always desirable, which is why the phrase is useful to anyone who wants nothing done in the meantime. The test is whether the person calling for it says what finding would change their position.
  • »Balance is not the same as accuracy. Giving equal space to two positions misinforms when the evidence is not equally divided. Readers can look for reporting that says where the weight of expert opinion lies, not only that disagreement exists.
  • »Disclosure is what ended it. The campaign survived decades of criticism and ended when internal documents became public through litigation. Legal discovery, archives and whistleblower protection are not peripheral to countering this kind of operation. They are the mechanism that worked.

Still contested

  • What the public already knew. In litigation the companies argued, with historians testifying as expert witnesses, that the dangers of smoking were common knowledge from the 1950s and that smokers therefore chose the risk. Proctor and Brandt respond that awareness of a claimed hazard is different from belief in it, and that the campaign was designed precisely to keep awareness from becoming belief. The role of historians as paid experts on either side is itself debated within the profession.
  • How much delay the campaign caused. The direction of the effect is not seriously disputed, but its size is. Addiction, advertising, price, social norms and weak regulation all sustained smoking, and no study cleanly separates the contribution of manufactured doubt from the rest.
  • Whether the remedy fitted the finding. As the 2006 opinion itself records, an earlier appeals ruling had held that the racketeering statute did not permit the government to recover past profits, so a finding of decades of fraud produced injunctions and corrective statements but no financial penalty in that case. Whether that outcome was adequate to the finding remains disputed.
  • How far the template generalises. Oreskes and Conway argue that the tobacco strategy was carried directly into later disputes over environmental science, in some cases by the same individuals. Critics accept the documented overlaps but caution against treating every industry-funded study or every scientific dissent as a repetition of the tobacco case, since that would make legitimate disagreement impossible to recognise.
  • Proctor's framing. Golden Holocaust argues for abolishing the sale of cigarettes and uses deliberately strong language, beginning with its title. Reviewers who accept its documentary findings have disagreed about both the policy conclusion and the rhetoric. The factual account of the doubt campaign does not depend on either.

Sources

  1. United States v. Philip Morris USA, Inc., 449 F. Supp. 2d 1 (D.D.C. 2006), amended final opinion (US Department of Justice copy)
    The court's findings of fact on the joint enterprise, the research bodies, the gap between internal knowledge and public statements, suppression of research, light and low-tar marketing, the role of lawyers, and the quoted characterisation of the defendants' conduct.
  2. Tobacco Control Laws (Campaign for Tobacco-Free Kids legal database), United States v. Philip Morris USA, et al., decision summary
    Plain-language summary of the judgment and remedies: injunctions, the ban on light and low-tar descriptors, corrective statements, fifteen years of document access, the outcome of the appeal, and the 2010 denial of Supreme Court review.
  3. Brown and Williamson, Smoking and Health Proposal (1969), Truth Tobacco Industry Documents, UCSF, document psdw0147
    The doubt is our product passage and the stated aim of establishing a controversy at the public level.
  4. A Frank Statement to Cigarette Smokers (4 January 1954), Truth Tobacco Industry Documents, UCSF, document fxmh0055
    The text of the advertisement, including the pledge of responsibility and the announcement of the research committee.
  5. Allan M. Brandt, Inventing Conflicts of Interest: A History of Tobacco Industry Tactics, American Journal of Public Health 102(1), 2012
    The December 1953 meeting, the Hill and Knowlton strategy, the Frank Statement's reach, the choice of scientific director, the direction of research funding away from smoking, the creation of the Tobacco Institute, and the conflicts-of-interest argument.
  6. Allan M. Brandt, The Cigarette Century (Basic Books, 2007)
    The full narrative history, including the 1964 report, the history of liability litigation, the 1994 congressional testimony, the document disclosures and the 1998 settlement.
  7. Robert N. Proctor, Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition (University of California Press, 2011)
    Document-based account of the campaign, the industry's own measurement of its effect, the common-knowledge defence and the role of historians as expert witnesses, and the abolition argument noted under contested points.
  8. Robert N. Proctor, The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll, Tobacco Control 21(2), 2012
    That the causal link was established in the 1940s and 1950s, that industry measurements showed its denial campaign succeeding, and that only one-third of US doctors accepted the case against cigarettes in 1960.
  9. Naomi Oreskes and Erik M. Conway, Merchants of Doubt (Bloomsbury Press, 2010); review in Isis 102(3)
    The recruitment of prominent scientists from other fields, the exploitation of journalistic balance, the secondhand smoke dispute, and the transfer of the strategy to later environmental controversies.
  10. US Department of Health and Human Services, The Health Consequences of Smoking: 50 Years of Progress, A Report of the Surgeon General, Executive Summary (2014)
    The conclusion that the industry deliberately misled the public, the estimate of more than 20 million premature deaths since 1964, and adult smoking prevalence in 1965 and 2012.
Last reviewed Suggest a correction